Navigation Links
The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients

rable" responses with improved tolerability, even in patients who had stopped responding to either drug when used alone. The data presented this week showed a 100 percent response rate in newly diagnosed patients and a 68 percent response rate in relapsed patients.

"The number of options available to treat myeloma patients today is growing with positive results from mature studies, as well as preliminary results from smaller trials," said Brian G.M. Durie, M.D. chairman and co- founder of the IMF. "What we are learning from using these novel combinations in myeloma is so promising that our findings may become applicable to many malignancies including lung, ovarian and other cancers. The progress we've begun in myeloma is encouraging for all cancer patients around the world."

Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affects production of red cells, white cells and stem cells. It affects an estimated 750,000 people worldwide, and in industrialized countries it is being diagnosed in growing numbers and in increasingly younger people.

ABOUT THE INTERNATIONAL MYELOMA FOUNDATION

The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 135,000 members in 113 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support and advocacy. To date, the IMF has conducted more than 120 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank On A Cure(R), a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE or http://www.myeloma.org, and in Spanish at http://www.myelomala.org.

Contact: Stephen Gendel

              The International Myel
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
Post Your Comments:
(Date:11/26/2014)...  At the American Dental Association,s Annual Meeting in ... Kerr Group was honored to be part of the ... to see and test the Best of Class winners ... on the latest developments in dental technology. This year, ... CariVu Caries Detection Device and Kerr Demi ™  ...
(Date:11/26/2014)... , Nov. 25, 2014   Heska Corporation (NASDAQ: ... the "Company"), a provider of advanced veterinary diagnostic and ... Grieve , Executive Chair, will attend The Benchmark Company, LLC,s ... one-on-one conference will be held at The Palmer House Hilton, ... from 8 a.m. to 2:30 p.m. Please email hska@haydenir.com ...
(Date:11/26/2014)... Nov. 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: ... corporate presentations at two upcoming investor conferences.  , ... on Tuesday, December 2, 2014 at 6:45 a.m. EST ... and head of EUSA International, will provide an overview of the ... Annual Piper Jaffray Healthcare Conference in New York, ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
... - Once-daily dosing with enteric-coated tablet produced robust antiviral ... ... was well tolerated during one week of dosing in HIV patients ... RDEA ) today announced additional positive results from its,completed Phase 2a ...
... 25 Vical Incorporated,(Nasdaq: VICL ) today ... under a three-year, $6.0 million grant awarded in,2007, ... DNA vaccine manufacturing,process with the potential to produce ... days., The RapidResponse(TM) system is designed to ...
Cached Medicine Technology:Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 2Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 3Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing 4Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 2Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 3Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 4Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH 5
(Date:11/26/2014)... The family foundation of Best Buy founder, ... Research Foundation (Meso Foundation), half of which will be ... Grant Program . The focus area of the Richard ... with organizations that can generate transformational results in education, ... founder and chairman emeritus of Best Buy Co., Inc., ...
(Date:11/26/2014)... 2014 Increasing incidence rate of ... regulations are expected to be prime pharmacovigilance market ... of acute and chronic ailments has resulted in ... development. Moreover, growing adverse drug reaction related hospitalization ... become the need of the hour in the ...
(Date:11/26/2014)... Francisco, CA (PRWEB) November 26, 2014 Gone ... hanker after cheap deals on Black Friday, which signifies the ... to clicking items into their shopping carts in the comfort ... crowds. , This Friday is going to be ... in a day, with an estimated $2.48 billion in revenue ...
(Date:11/26/2014)... Loffler Companies has been selected as a 2014 ... information and news publication for resellers of imaging technology, ... Loffler has earned this prestigious award and the seventh ... honor the best and the brightest in the imaging ... chosen for their innovative marketing and sales programs, community ...
(Date:11/26/2014)... 26, 2014 GI for Life announced ... reductions in prices of their popular nutritional supplements: ... D3 . Discounts of 40% will be offered ... for Life’s proprietary ColoVite supplement is a scientifically formulated ... colon health. One easy-to-take colon vitamin with ALL the ...
Breaking Medicine News(10 mins):Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 2Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 3Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2
... Doctors Ritu Chopra and Andrew Ordon, respected physicians with practices ... women to obtain regular breast exams and to be aware ... awareness month, and a good time to urge all women ... general and breast cancer surgeon. "Women should be taking the ...
... , , ATLANTA, Oct. 12 ... has donated $25,000 to the American Red Cross for the ... in Georgia have caused widespread flooding and damage throughout metro ... of its counties declared ,disaster areas, including Carroll, Catoosa, Chattooga, ...
... Aon Corporation (NYSE: AOC ) today announced that the Board ... share on outstanding common stock. The dividend is payable on November ... About Aon , Aon Corporation ... risk management services, insurance and reinsurance ...
... to lead new sports neurology division of American Academy of ... the football field, the hockey rink or wrestling mat, an ... of Michigan neurologist is leading the charge to help doctors ... Jeffrey S. Kutcher, M.D., a sports neurologist and assistant professor ...
... PORTLAND, Ore., Oct. 12 What if you could not ... the most basic items? What if the check-out clerk offered ... what your total amount would be? , Although that sounds ... often operates. , As the country,s health care reform debate ...
... pain, infections and other health woes, study finds , ... romantic partners are more likely to suffer from a ... new study shows. , The diseases, many of which ... pain, headaches, acid reflux, urinary tract infections and menstrual ...
Cached Medicine News:Health News:Renowned Southern California Doctors Emphasizing Early Detection During Breast Cancer Awareness Month 2Health News:Blue Cross and Blue Shield of Georgia Foundation Donates $25,000 to Red Cross for Flood Relief Efforts in Georgia 2Health News:Aon Declares Quarterly Dividend 2Health News:U-M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 2Health News:U-M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 3Health News:Regence Video Asks 'What if Everything Worked Like Health Care?' 2Health News:Regence Video Asks 'What if Everything Worked Like Health Care?' 3Health News:Battered Women's Ills Go Beyond Bruises 2
...
...
...
... plate system features an advanced design that ... Trinica system gives surgeons the flexibility to ... anatomy. Flexibility is built-in to every aspect ... the innovative Secure-Twist anti-migration system to the ...
Medicine Products: